Literature DB >> 24343621

Can routinely collected national data on childhood morbidity and mortality from diarrhea be used to monitor health impact of rotavirus vaccination in Africa? Examination of pre-vaccine baseline data from Rwanda.

Fidele Ngabo1, Maurice Gatera, Corrine Karema, Philippe Donnen, Philippe Lepage, Umesh D Parashar, Jacqueline E Tate, Jason M Mwenda, Celse Rugambwa, Agnès Binagwaho.   

Abstract

BACKGROUND: As rotavirus vaccine is introduced into routine childhood immunization programs in Africa, understanding its impact on diarrheal disease burden is important. The objective of this analysis was to determine whether routinely collected health information on national diarrhea hospitalizations, in-hospital deaths and outpatient visits would be useful to monitor rotavirus vaccine impact.
METHODS: We analyzed data for all-cause, nonbloody diarrheal disease among children <5 years of age from the routine health management information system (HMIS) in Rwanda from January 2008 through December 2011. We described trends in absolute numbers of inpatient admissions, in-hospital deaths and outpatient visits by year, age and setting.
RESULTS: All-cause, nonbloody diarrheal hospitalizations and outpatient visits among children <5 years of age in Rwanda from 2008 to 2011 peaked during the June to August dry season, coinciding with the rotavirus season. The bulk of the diarrheal disease burden occurred in children <1 year of age. Health centers provided many care to children with diarrhea including 60-72% of hospitalizations and 97-99% of outpatient visits. Many in-hospital diarrheal deaths (84%) occurred in district hospitals. DISCUSSION: Given the stable and consistent trends and the prominent seasonality consistent with that of rotavirus, HMIS data should provide a useful baseline to monitor rotavirus vaccine impact on the overall diarrheal disease burden in Rwanda. Active, sentinel surveillance for rotavirus diarrhea will help interpret changes in diarrheal disease trends following vaccine introduction. Other countries planning rotavirus vaccine introduction should explore the availability and quality of their HMIS data.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24343621     DOI: 10.1097/INF.0000000000000054

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  5 in total

1.  Maternal Antiretroviral Therapy Is Associated with Lower Risk of Diarrhea in Early Childhood.

Authors:  Kevin A Sztam; Enju Liu; Karim P Manji; Roland Kupka; Rodrick Kisenge; Said Aboud; Wafaie W Fawzi; Ronald J Bosch; Christopher P Duggan
Journal:  J Pediatr       Date:  2016-05-28       Impact factor: 4.406

2.  Hospitalizations and Deaths Because of Respiratory and Diarrheal Diseases Among Haitian Children Under Five Years of Age, 2011-2013.

Authors:  Kavita Vinekar; Nicolas Schaad; Mentor Ali Ber Lucien; Eyal Leshem; Ikwo K Oboho; Gerard Joseph; Stanley Juin; Fatimah S Dawood; Umesh Parashar; Mark A Katz; Rania A Tohme
Journal:  Pediatr Infect Dis J       Date:  2015-10       Impact factor: 2.129

3.  Rates of hospitalization and death for all-cause and rotavirus acute gastroenteritis before rotavirus vaccine introduction in Kenya, 2010-2013.

Authors:  Richard Omore; Sammy Khagayi; Billy Ogwel; Reuben Onkoba; John B Ochieng; Jane Juma; Stephen Munga; Collins Tabu; Sergon Kibet; J Pekka Nuorti; Frank Odhiambo; Jason M Mwenda; Robert F Breiman; Umesh D Parashar; Jacqueline E Tate
Journal:  BMC Infect Dis       Date:  2019-01-11       Impact factor: 3.090

4.  The Economic Burden Attributable to a Child's Inpatient Admission for Diarrheal Disease in Rwanda.

Authors:  Fidele Ngabo; Mercy Mvundura; Lauren Gazley; Maurice Gatera; Celse Rugambwa; Eugene Kayonga; Yvette Tuyishime; Jeanne Niyibaho; Jason M Mwenda; Philippe Donnen; Philippe Lepage; Agnes Binagwaho; Deborah Atherly
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

5.  Whole genome and in-silico analyses of G1P[8] rotavirus strains from pre- and post-vaccination periods in Rwanda.

Authors:  Sebotsana Rasebotsa; Peter N Mwangi; Milton T Mogotsi; Saheed Sabiu; Nonkululeko B Magagula; Kebareng Rakau; Jeannine Uwimana; Leon Mutesa; Narcisse Muganga; Didier Murenzi; Lisine Tuyisenge; Jose Jaimes; Mathew D Esona; Michael D Bowen; M Jeffrey Mphahlele; Mapaseka L Seheri; Jason M Mwenda; Martin M Nyaga
Journal:  Sci Rep       Date:  2020-08-10       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.